Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

212 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
10-year follow-up of intensive glucose control in type 2 diabetes.
Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. Holman RR, et al. Among authors: paul sk. N Engl J Med. 2008 Oct 9;359(15):1577-89. doi: 10.1056/NEJMoa0806470. Epub 2008 Sep 10. N Engl J Med. 2008. PMID: 18784090 Clinical Trial.
Long-term follow-up after tight control of blood pressure in type 2 diabetes.
Holman RR, Paul SK, Bethel MA, Neil HA, Matthews DR. Holman RR, et al. Among authors: paul sk. N Engl J Med. 2008 Oct 9;359(15):1565-76. doi: 10.1056/NEJMoa0806359. Epub 2008 Sep 10. N Engl J Med. 2008. PMID: 18784091 Clinical Trial.
Atorvastatin in Factorial with Omega-3 EE90 Risk Reduction in Diabetes (AFORRD): a randomised controlled trial.
Holman RR, Paul S, Farmer A, Tucker L, Stratton IM, Neil HA; Atorvastatin in Factorial with Omega-3 EE90 Risk Reduction in Diabetes Study Group. Holman RR, et al. Diabetologia. 2009 Jan;52(1):50-9. doi: 10.1007/s00125-008-1179-5. Epub 2008 Nov 11. Diabetologia. 2009. PMID: 19002433 Clinical Trial.
Three-year efficacy of complex insulin regimens in type 2 diabetes.
Holman RR, Farmer AJ, Davies MJ, Levy JC, Darbyshire JL, Keenan JF, Paul SK; 4-T Study Group. Holman RR, et al. Among authors: paul sk. N Engl J Med. 2009 Oct 29;361(18):1736-47. doi: 10.1056/NEJMoa0905479. Epub 2009 Oct 22. N Engl J Med. 2009. PMID: 19850703 Clinical Trial.
Effects of HbA1c and weight reduction on blood pressure in patients with type 2 diabetes mellitus treated with exenatide*.
Paul S, Best J, Klein K, Han J, Maggs D. Paul S, et al. Diabetes Obes Metab. 2012 Sep;14(9):826-34. doi: 10.1111/j.1463-1326.2012.01609.x. Epub 2012 May 16. Diabetes Obes Metab. 2012. PMID: 22510305 Clinical Trial.
Obesity paradox in people newly diagnosed with type 2 diabetes with and without prior cardiovascular disease.
Thomas G, Khunti K, Curcin V, Molokhia M, Millett C, Majeed A, Paul S. Thomas G, et al. Diabetes Obes Metab. 2014 Apr;16(4):317-25. doi: 10.1111/dom.12217. Epub 2013 Oct 29. Diabetes Obes Metab. 2014. PMID: 24118783
Rationale, design, and organization of a randomized, controlled Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in patients with type 2 diabetes and established cardiovascular disease.
Green JB, Bethel MA, Paul SK, Ring A, Kaufman KD, Shapiro DR, Califf RM, Holman RR. Green JB, et al. Among authors: paul sk. Am Heart J. 2013 Dec;166(6):983-989.e7. doi: 10.1016/j.ahj.2013.09.003. Epub 2013 Oct 23. Am Heart J. 2013. PMID: 24268212 Clinical Trial.
Dynamic risk factors associated with non-severe hypoglycemia in patients treated with insulin glargine or exenatide once weekly.
Paul SK, Maggs D, Klein K, Best JH. Paul SK, et al. J Diabetes. 2015 Jan;7(1):60-7. doi: 10.1111/1753-0407.12208. Epub 2014 Dec 17. J Diabetes. 2015. PMID: 25168883
Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: a cohort study.
Khunti K, Davies M, Majeed A, Thorsted BL, Wolden ML, Paul SK. Khunti K, et al. Among authors: paul sk. Diabetes Care. 2015 Feb;38(2):316-22. doi: 10.2337/dc14-0920. Epub 2014 Dec 9. Diabetes Care. 2015. PMID: 25492401
Comparison of trajectories of self-monitored glucose levels by hypoglycemia status over 52 weeks of treatment with insulin glargine or exenatide once weekly.
Paul SK, Agbeve J, Maggs D, Best JH. Paul SK, et al. J Diabetes. 2016 Jan;8(1):148-57. doi: 10.1111/1753-0407.12269. Epub 2015 Mar 24. J Diabetes. 2016. PMID: 25586464
212 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback